Table 1:
Antibody Clones | T-Cell | T-ALL | B-Cells | B-ALL | CD34+ | AML | MDS | Subtype | Target Species | Epitopes |
---|---|---|---|---|---|---|---|---|---|---|
DN16 | Co-stimulation along with suboptimal CD3 mAb OKT3 enhanced proliferation of T-cells and stimulation of IL-2.52 | Induction of HSP70 in Jurkat cells.44 Induced homotypic cell aggregation of Jurkat T-cells and cell apoptosis.45 | Induction of cell death of undifferentiated B-cell precursors.46 | Induction of HSP70 in REH cells.44 Induces cell apoptosis of BCP-ALL.46 | IgG | Mouse (reacts with Human) | Recognizes ‘LPDNENKK’ sequence located between residues 32 and 39 towards the N-terminus.56 | |||
YG32 | Induced homotypic aggregation of Jurkat T-cells but no cell apoptosis. However, it enhanced Fas-mediated cell death.45 | IgG | Mouse | Recognizes ‘RPPNPPK’ sequence between residues 68 and 74.56 | ||||||
12E7 | Does not induce cell death of thymocytes.10 | Does not induce cell apoptosis.46 | Slight protection from apoptosis, inhibits transendothelial migration of CD34+ and homing to bone marrow.53 | IgG1 | Mouse | Recognizes ‘DGEN’ sequence between residues 61~64.28 | ||||
0062 | Inhibit T-cell rosette formation. Induced cell death of thymocytes.10 | Induced cell death of Jurkat T-cells.10 | Induction of cell death of undifferentiated B-cell precursors.46 | Induction of HSP70 in REH cells.44 Does not induce cell apoptosis.46 | Does not induce apoptosis and has no effect on cell migration.53 | Human | Recognizes ‘GSFSDADLAD’ sequence between residues 88~97.28 | |||
TU12 | Enhanced CD4+ cell proliferation in the presence of CD3 costimulation.54 | IgG2 | Mouse | |||||||
Hec2 | Induction of HSP70 in REH cells.44 | Does not induce apoptosis and has no effect on cell migration.53 | ||||||||
3B2/TA8 | Enhanced proliferation of peripheral blood T-cells along with CD3 mAb.53 | Increased IL-2 promoter activity in Jurkat cells in the presence of CD3 mAb.53 | Does not induce cell apoptosis.46 | IgG2 | Mouse | |||||
AD20 | Induces cell aggregation and apoptosis in Jurkat T-cells.55 | IgM | Human | |||||||
HO36-1.1 | Induces apoptosis in Jurkat T-cells.55 | Cytotoxic to AML cell lines and myeloid blasts.19 | Cytotoxic to purified primary MDS CD34+ cells.19 | IgM | Mouse |
Antibody Comparisons in Hematological Malignancies | |||||||
---|---|---|---|---|---|---|---|
Antibody Clones | T-Cell | T-ALL | B-Cells | B-ALL | CD34+ | AML | MDS |
DN16 | Co-stimulation along with suboptimal CD3 mAb OKT3 enhanced proliferation of T-cells and stimulation of IL-2.52 | Induction of HSP70 in Jurkat cells.44 Induced homotypic cell aggregation of Jurkat T-cells and cell apoptosis.45 | Induction of cell death of undifferentiated B-cell precursors.46 | Induction of HSP70 in REH cells.44 Induces cell apoptosis of BCP-ALL.46 | |||
YG32 | Induced homotypic aggregation of Jurkat T-cells but no cell apoptosis. However, it enhanced Fas-mediated cell death.45 | ||||||
12E7 | Does not induce cell death of thymocytes.10 | Does not induce cell apoptosis.46 | Slight protection from apoptosis, inhibits transendothelial migration of CD34+ and homing to bone marrow.53 | ||||
0062 | Inhibit T-cell rosette formation. Induced cell death of thymocytes.10 | Induced cell death of Jurkat T-cells.10 | Induction of cell death of undifferentiated B-cell precursors.46 | Induction of HSP70 in REH cells.44 Does not induce cell apoptosis.46 | Does not induce apoptosis and has no effect on cell migration.53 | ||
TU12 | Enhanced CD4+ cell proliferation in the presence of CD3 costimulation.54 | ||||||
Hec2 | Induction of HSP70 in REH cells.44 | Does not induce apoptosis and has no effect on cell migration.53 | |||||
3B2/TA8 | Enhanced proliferation of peripheral blood T-cells along with CD3 mAb.53 | Increased IL-2 promoter activity in Jurkat cells in the presence of CD3 mAb.53 | Does not induce cell apoptosis.46 | ||||
AD20 | Induces cell aggregation and apoptosis in Jurkat T-cells.55 | ||||||
HO36-1.1 | Induces apoptosis in Jurkat T-cells.55 | Cytotoxic to AML cell lines and myeloid blasts.19 | Cytotoxic to purified primary MDS CD 34+ cells19 |
Antibody Characteristic Comparisons | |||
---|---|---|---|
Antibody | Subtype | Target Species | Epitopes |
DN16 | IgG | Mouse (reacts with Human] | Recognizes ‘LPDNENKK’ sequence located between residues 32 and 39 towards the N-terminus.56 |
YG32 | IgG | Mouse | Recognizes ‘RPPNPPK’ sequence between residues 68 and 74.56 |
12E7 | IgG1 | Mouse | Recognizes ‘DGEN’ sequence between residues 61~64.28 |
0062 | Human | Recognizes ‘GSFSDADLAD’ sequence between residues 88~97.28 | |
TU12 | IgG2 | Mouse | |
3B2/TA8 | IgG2 | Mouse | |
AD20 | IgM | Human | |
HO36-1.1 | IgM | Mouse |